Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Systematic Review and Meta-Analysis on the Age-Specific Seroprevalence of Hepatitis a in Iran



Farajzadegan Z1 ; Hoseini SG2 ; Kelishadi R3 ; Jamshidi F2 ; Nokhodian Z4 ; Noori R5 ; Mirmoghtadaee P1 ; Hovsepian S3 ; Mostafavi SN1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Departments of Community and Preventive Medicine, Child Growth and Development Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  2. 2. Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  3. 3. Pediatrics Department, Child Growth and Development Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  4. 4. Nosocomial Infection Research Center, Isfahan University of Medical Sciences, Isfahan, Iran
  5. 5. Department of Medical Library and Information Sciences, School of Management and Medical Information, Isfahan University of Medical Sciences, Isfahan, Iran

Source: Journal of Research in Medical Sciences Published:2014

Abstract

Background: Hepatitis A virus (HAV) is a major cause of acute viral hepatitis worldwide. Annual medical and work loss costs of hepatitis A are significant even in low-endemic countries. It is recommended that each country should collect and review the information needed to estimate its national burden of hepatitis A to provide evidence for health policy makers to implement appropriate and cost-eff ective preventive strategy for HAV infection. Th e objective of this study was to estimate accurate prevalence of HAV infection in Iran for best preventive measures. Materials and Methods: MEDLINE, Institute of Scientific Information, Scopus, Iranmedex, Irandoc, Magiran and Scientific Information Database were searched. Th e seroprevalence of HAV were pooled by age, sex and residence using fixed and random eff ect models. Results: Sixteen papers representing 11857 subjects were included. Th e overall HAV seroprevalence was 51% (confidence interval [CI] 95%: 50-52%) in fixed and 66% (95% CI: 50-79%) in random eff ects models. Th e prevalence was 32% (CI 95%: 11-63%) in less than 20, 50% (CI 95%: 24-75%) in 20-30, and 67% (CI 95%: 17-95%) in more than 30 years of age. Th e diff erence was not significant in gender or residence subgroups. Conclusion: HAV infection in Iran may be considered as low or very low. Th erefore, targeted vaccination of high-risk groups and more improvement in environmental sanitation would be the best preventive measure.
Other Related Docs
14. Seroprevalence of Hepatitis a Among Street Children, Isfahan, Iran, Journal of Isfahan Medical School (2012)
18. Attitudes Towards Maternal Screening for Hepatitis B Virus Infection in Iran., Tropical gastroenterology : official journal of the Digestive Diseases Foundation (2010)
21. Hepatitis C Virus Infection in Patients With Hemophilia in Isfahan, Iran, International Journal of Preventive Medicine (2012)
38. Assessment of Hepatitis C Risk Factors in Center of Iran: A Case-Control Study, Journal of Research in Medical Sciences (2018)
39. Seroprevalence of Hepatitis B in Nahavand, Islamic Republic of Iran, Eastern Mediterranean Health Journal (2006)
41. Hepatitis C in Correctional Centers: A Useful Experience, Journal of Isfahan Medical School (2011)
42. Prevalence of Hepatitis B Virus Infection in Isfahan Province, International Journal of Preventive Medicine (2014)
48. Hepatitis C Seroprevalence Among Intravenous Drug Users in Tehran, Journal of Research in Medical Sciences (2008)